decriminalisation

We must seriously consider decriminalisation for patients unable to access cannabis-based medicines on the NHS

We must seriously consider decriminalisation for patients unable to access cannabis-based medicines on the NHS

David King, Senior Researcher

The draft NICE guidelines for the use of Cannabis-based medicinal products (CBMPs), which were published last week, contained no recommendations for the use of CBMPs except nabilone as an add-on treatment for adults suffering from intractable nausea and vomiting. Thus, for now, prescriptions of CBMPs on the NHS are likely to remain effectively unavailable. That these guidelines were highly restrictive and risk-averse came as no surprise to most, but nonetheless a huge disappointment for many.